BMO Capital Markets Increases AbbVie (NYSE:ABBV) Price Target to $220.00
AbbVie (NYSE:ABBV – Free Report) had its price objective boosted by BMO Capital Markets from $214.00 to $220.00 in a report released on Thursday morning, Benzinga reports. The firm currently has an outperform rating on the stock. Other equities analysts also recently issued research reports about the company. Piper Sandler Companies reiterated an “overweight” rating […]
More Stories
Ally Financial (NYSE:ALLY) Lifted to Market Perform at Raymond James
Ally Financial (NYSE:ALLY – Get Free Report) was upgraded by Raymond James from an “underperform” rating to a “market perform”...
Augur 1-Day Trading Volume Hits $98,461.38 (REP)
Augur (REP) traded down 0.1% against the US dollar during the 24-hour period ending at 7:00 AM ET on October...
Cindicator Price Down 17.8% Over Last 7 Days (CND)
Cindicator (CND) traded flat against the U.S. dollar during the 1 day period ending at 7:00 AM ET on October...
Venus USDC Reaches One Day Trading Volume of $117.30 Million (vUSDC)
Venus USDC (vUSDC) traded 0% higher against the U.S. dollar during the 1 day period ending at 7:00 AM ET...
WhiteBIT Token (WBT) Reaches 24-Hour Volume of $4.91 Million
WhiteBIT Token (WBT) traded 1.1% higher against the dollar during the 24-hour period ending at 7:00 AM E.T. on October...
Beta Finance One Day Volume Tops $1.63 Million (BETA)
Beta Finance (BETA) traded 1.8% higher against the dollar during the 24 hour period ending at 8:00 AM Eastern on...